Anas Subarnas
Impact in
- Pharmacology top 2%
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Medicinal Plant Research 23
- Phytochemistry and Biological Activities 7
-
- Natural product bioactivities and synthesis 8
- Co-authors
- Muchtaridi Muchtaridi (14 shared papers)Ajeng Diantini (19 shared papers)Hildebert Wagner (1 shared paper)Yoshiteru Oshima (5 shared papers)Taofik Rusdiana (12 shared papers)Rizky Abdulah (11 shared papers)Hiroshi Koyama (7 shared papers)Anton Apriyantono (1 shared paper)
In The Last Decade
Anas Subarnas
101 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 115
- Pharmacology 180
- Biochemistry 110
- Complementary and alternative medicine 139
- Toxicology 54
- Pharmaceutical Science 91
Countries citing papers authored by Anas Subarnas
This map shows the geographic impact of Anas Subarnas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Subarnas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Subarnas more than expected).
Fields of papers citing papers by Anas Subarnas
This network shows the impact of papers produced by Anas Subarnas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Subarnas. The network helps show where Anas Subarnas may publish in the future.
Co-authors
The 25 scholars most cited alongside Anas Subarnas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 107 | |
| 2 | 2010 | 81 | |
| 3 | 2017 | 72 | |
| 4 | 2020 | 67 | |
| 5 | 2000 | 65 | |
| 6 | 1991 | 50 | |
| 7 | 1993 | 41 | |
| 8 | 2020 | 38 | |
| 9 | 2014 | 35 | |
| 10 | 2014 | 34 | |
| 11 | 2014 | 29 | |
| 12 | 2012 | 27 | |
| 13 | 2020 | 26 | |
| 14 | 2015 | 25 | |
| 15 | 2019 | 22 | |
| 16 | 1993 | 20 | |
| 17 | 1992 | 16 | |
| 18 | 2021 | 16 | |
| 19 | 2012 | 15 | |
| 20 | 2022 | 14 |
About Anas Subarnas
Anas Subarnas is a scholar working on Plant Science, Molecular Biology, Food Science, General Health Professions and General Agricultural and Biological Sciences, having authored 111 papers that have together received 1.2k indexed citations. Recurring topics across this work include Medicinal Plant Research (23 papers), Natural Products and Applications (11 papers), Computational Drug Discovery Methods (10 papers), Natural product bioactivities and synthesis (8 papers), Natural Antidiabetic Agents Studies (8 papers), Advanced Drug Delivery Systems (8 papers), Phytochemistry and Biological Activities (7 papers) and Bioactive Compounds and Antitumor Agents (6 papers). The work is most often cited by research in Pharmacology (180 citations), Biochemistry (110 citations), Complementary and alternative medicine (139 citations), Toxicology (54 citations) and Pharmaceutical Science (91 citations). Anas Subarnas has collaborated with scholars based in Indonesia, Japan and Malaysia. Frequent co-authors include Muchtaridi Muchtaridi, Ajeng Diantini, Hildebert Wagner, Yoshiteru Oshima, Taofik Rusdiana, Rizky Abdulah, Hiroshi Koyama, Anton Apriyantono, Resmi Mustarichie and Iyan Sopyan. Their work appears in journals such as International Journal of Applied Pharmaceutics, Biomedical Reports, Toxicology Reports, Pharmaceuticals and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.